Page 5 of 7
ACS Medicinal Chemistry Letters
enhanced plasma stability and prolonged in vivo glucose-
lowering ability. Br. J. Pharmacol. 2014, 171 (23), 5252-5264.
4. Wang, G.; Peng, Z.; He, D.; Yan, C.; Liu, W. Coumarin-
isatin type compound useful in treatment of diabetes mellitus
and its preparation. CN105237521A, 2016.
transmembrane, tumor-associated carbonic anhydrase
isoforms IX and XII over the cytosolic ones I and II. Bioorg.
Med. Chem. Lett. 2010, 20 (15), 4511-4.
1
2
3
4
5
6
7
18.
Nocentini, A.; Carta, F.; Ceruso, M.; Bartolucci, G.;
Supuran, C. T., Click-tailed coumarins with potent and
selective inhibitory action against the tumor-associated
carbonic anhydrases IX and XII. Bioorg. Med. Chem. 2015, 23
(21), 6955-6966.
5.
Mercer, D. K.; Robertson, J.; Wright, K.; Miller, L.;
Smith, S.; Stewart, C. S.; O′Neil, D. A., A prodrug approach to
the use of coumarins as potential therapeutics for superficial
mycoses. PLoS One 2013, 8 (11), e80760.
19.
De Luca, L.; Mancuso, F.; Ferro, S.; Buemi, M. R.;
8
9
6.
Musa, M. A.; Cooperwood, J. S.; Khan, M. O. F., A
Angeli, A.; Del Prete, S.; Capasso, C.; Supuran, C. T.; Gitto, R.,
Inhibitory effects and structural insights for a novel series of
coumarin-based compounds that selectively target human CA
IX and CA XII carbonic anhydrases. Eur. J. Med. Chem. 2018,
143, 276-282.
review of coumarin derivatives in pharmacotherapy of breast
cancer. Curr. Med. Chem. 2008, 15 (26), 2664-2679.
7.
Y.; Piao, L. X.; Xu, G. H.; Li, X.; Quan, Z. S.; Jin, X., Imperatorin
suppresses proliferation and angiogenesis of human colon
cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-
BP1 and MAPK pathways. J. Ethnopharmacol. 2017, 203, 27-
38.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Mi, C.; Ma, J.; Wang, K. S.; Zuo, H. X.; Wang, Z.; Li, M.
20.
Supuran, C. T., Inhibition of carbonic anhydrase IX as
a novel anticancer mechanism. World J. Clin. Oncol. 2012, 3
(7), 98-103.
21.
Winum, J.-Y.; Rami, M.; Scozzafava, A.; Montero, J.-L.;
8.
Xia, W.; Gooden, D.; Liu, L.; Zhao, S.; Soderblom, E. J.;
Supuran, C., Carbonic anhydrase IX: a new druggable target
for the design of antitumor agents. Med. Res. Rev. 2008, 28 (3),
445-463.
Toone, E. J.; Beyer, W. F.; Walder, H.; Spector, N. L., Photo-
activated psoralen binds the ErbB2 catalytic kinase domain,
blocking ErbB2 signaling and triggering tumor cell apoptosis.
PLoS One 2014, 9 (2), e88983/1-e88983/10, 10 pp.
22.
Cecchi, A.; Hulikova, A.; Pastorek, J.; Pastorekova, S.;
Scozzafava, A.; Winum, J. Y.; Montero, J. L.; Supuran, C. T.,
Carbonic anhydrase inhibitors. Design of fluorescent
sulfonamides as probes of tumor-associated carbonic
anhydrase IX that inhibit isozyme IX-mediated acidification of
hypoxic tumors. J. Med. Chem. 2005, 48 (15), 4834-41.
9.
Leanza, L.; Romio, M.; Becker, K. A.; Azzolini, M.;
Trentin, L.; Manago, A.; Venturini, E.; Zaccagnino, A.; Mattarei,
A.; Carraretto, L.; Urbani, A.; Kadow, S.; Biasutto, L.; Martini, V.;
Severin, F.; Peruzzo, R.; Trimarco, V.; Egberts, J.-H.; Hauser, C.;
Visentin, A.; Semenzato, G.; Kalthoff, H.; Zoratti, M.; Gulbins, E.;
Paradisi, C.; Szabo, I., Direct pharmacological targeting of a
mitochondrial ion channel selectively kills tumor cells in vivo.
Cancer Cell 2017, 31 (4), 516-531.e10.
23.
Supuran, C. T.; Winum, J. Y., Carbonic anhydrase IX
inhibitors in cancer therapy: an update. Future Med Chem
2015, 7 (11), 1407-14.
24.
Araste, F.; Ebrahimizadeh, W.; Rasooli, I.; Rajabibazl,
10.
Min, K.-J.; Um, H. J.; Seo, S. U.; Woo, S. M.; Kim, S.;
M.; Mousavi Gargari, S. L., A novel VHH nanobody against the
active site (the CA domain) of tumor-associated, carbonic
anhydrase isoform IX and its usefulness for cancer diagnosis.
Biotechnol. Lett. 2014, 36 (1), 21-28.
Park, J.-W.; Lee, H.-S.; Kim, S. H.; Choi, Y. H.; Lee, T.-J.; Kwon, T.
K., Angelicin potentiates TRAIL-induced apoptosis in renal
carcinoma Caki cells through activation of caspase 3 and
down-regulation of c-FLIP expression. Drug Dev. Res. 2018, 79
(1), 3-10.
25.
De Simone, G.; Supuran, C. T., Carbonic anhydrase IX:
Biochemical and crystallographic characterization of a novel
11.
Gustafson, K. R.; Fuller, R. W.; Cardellina, J. H., II;
antitumor target. Biochimica et Biophysica Acta (BBA)
Proteins and Proteomics 2010, 1804 (2), 404-409.
-
McMahon, J. B.; Currens, M. J.; Boyd, M. R.; Kashman, Y.;
Buckheit, R. W., Jr.; Hughes, S. H.; Cragg, G. M., The Calanolides,
a novel HIV-inhibitory class of coumarin derivatives from the
tropical rainforest tree, Calophyllum lanigerum. J. Med. Chem.
1992, 35 (15), 2735-2743.
26.
Kameyama, K.; Mizutani, K.; Deguchi, T.; Ito, M., Exosomes
expressing carbonic anhydrase promote angiogenesis.
Biochem. Biophys. Res. Commun. 2017, 492 (3), 356-361.
27. Supuran, C. T., Structure and function of carbonic
anhydrases. Biochem. J. 2016, 473 (14), 2023-32.
28. Jiang, J.; Zhao, J. H.; Wang, X. L.; Guo, X. J.; Yang, J.; Bai,
Horie, K.; Kawakami, K.; Fujita, Y.; Sugaya, M.;
9
12.
Kozioł, E.; Skalicka-Woźniak, K., Imperatorin–
pharmacological meaning and analytical clues: profound
investigation. Phytochem. Rev. 2016, 15 (4), 627-649.
13.
Chiang, C. C.; Cheng, M. J.; Peng, C. F.; Huang, H. Y.;
novel dimeric coumarin analog and
X.; Jin, S. Y.; Ge, R. L., Correlation between carbonic anhydrase
IX (CA-9), XII (CA-12) and hypoxia inducible factor-2α (HIF-
2α) in breast cancer. Neoplasma 2015, 62 (3), 456-463.
Chen, I. S.,
A
antimycobacterial constituents from Fatoua pilosa. Chemistry
and Biodiversity 2010, 7 (7), 1728-1736.
14.
H.-L., Psoralen reverses docetaxel-induced multidrug
resistance in A549/D16 human lung cancer cells lines.
Phytomedicine 2014, 21 (7), 970-977.
29.
Rajabi, M.; Hossaini, Z.; Khalilzadeh, M. A.; Datta, S.;
Hsieh, M.-J.; Chen, M.-K.; Yu, Y.-Y.; Sheu, G.-T.; Chiou,
Halder, M.; Mousa, S. A., Synthesis of a new class of furo[3,2-
c]coumarins and its anticancer activity. J. Photochem.
Photobiol. B 2015, 148, 66-72.
30.
Abdel Hafez, O. M.; Amin, K. M.; Abdel-Latif, N. A.;
15.
Jiang, J.; Wang, X.; Cheng, K.; Zhao, W.; Hua, Y.; Xu, C.;
Mohamed, T. K.; Ahmed, E. Y.; Maher, T., Synthesis and
antitumor activity of some new xanthotoxin derivatives. Eur. J.
Med. Chem. 2009, 44 (7), 2967-74.
Yang, Z., Psoralen reverses the P-glycoprotein-mediated
multidrug resistance in human breast cancer MCF-7/ADR
cells. Mol. Med. Rep. 2016, 13 (6), 4745-4750.
31.
Melis, C.; Meleddu, R.; Angeli, A.; Distinto, S.; Bianco,
16.
Touisni, N.; Maresca, A.; McDonald, P. C.; Lou, Y.;
G.; Capasso, C.; Cottiglia, F.; Angius, R.; Supuran, C. T.;
Maccioni, E., Isatin: a privileged scaffold for the design of
carbonic anhydrase inhibitors. J. Enzyme Inhib. Med. Chem.
2017, 32 (1), 68-73.
Scozzafava, A.; Dedhar, S.; Winum, J.-Y.; Supuran, C. T.,
Glycosyl coumarin carbonic anhydrase IX and XII inhibitors
strongly attenuate the growth of primary breast tumors. J.
Med. Chem. 2011, 54 (24), 8271-8277.
32.
Bianco, G.; Meleddu, R.; Distinto, S.; Cottiglia, F.;
17.
Maresca, A.; Supuran, C. T., Coumarins incorporating
Gaspari, M.; Melis, C.; Corona, A.; Angius, R.; Angeli, A.;
Taverna, D.; Alcaro, S.; Leitans, J.; Kazaks, A.; Tars, K.; Supuran,
hydroxy- and chloro-moieties selectively inhibit the
ACS Paragon Plus Environment